Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Recruiting 73Completed 45Active not recruiting 43Terminated 23Withdrawn 10Not yet recruiting 7Unknown 3Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Mesothelioma, Malignant 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × abemaciclib × Clear all
NCT05464173 2024-01-22

CINDERELLA

Fudan University

Phase 1/2 Unknown
44 enrolled
Breast

Breast Neoplasms

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03356587 2017-11-29

A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based Therapy

Seoul National University Hospital

Phase 2 Unknown
32 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡